Skye Bioscience, Inc. (SKYE)

Import this data to Google Sheets with:

=jivedata("SKYE","financials")

Full statements spill as a table. For one cell: =jivedata("SKYE","Revenue") or =jivedata("SKYE","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Skye Bioscience, Inc.

SKYE • CIK 0001516551

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Research and Development Expense (Excluding Acquired in Process Cost)	$5,819.461	$18,701.694	$42,361.879	$32,704.481
General and Administrative Expense	$7,852.34	$17,725.741	$15,801.686	$15,941.266
Operating Income (Loss)	$-34,735.173	$-30,192.718	$-58,163.565	$-51,895.747
Loss Contingency Accrual, Provision	$-151.843	$-4,234.717	$0	$0
Insurance Recoveries	—	$2,000	$0	$0
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-37,641.184	$-26,557.052	$-55,919.414	$-50,489.178
Operating Expenses	$34,735.173	$30,192.718	$58,163.565	$51,895.747
Income Tax Expense (Benefit)	$3.6	$10.071	$5.4	$3.4
Net Income (Loss) Attributable to Parent	$-37,644.784	$-26,567.123	$-55,924.814	$-50,492.578
InterestExpenseNonoperating	—	$749.308	$0	$5.498
Investment Income, Interest	$99.974	$3,028.762	$1,883.903	$965.393
Gain (Loss) on Disposition of Business	$-307.086	$1,358.412	$360.75	$449.587
Other Nonoperating Income (Expense)	—	$-2.2	$-0.502	$-2.913
Nonoperating Income (Expense)	$-2,906.011	$3,635.666	$2,244.151	$1,406.569
Weighted Average Number of Shares Outstanding, Basic	7,006,038	36,486,519	39,662,664	39,694,485

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	—	$68,415.741	$5,882.498	$8,068.357
Short-term Investments	—	—	$19,854.723	$1,995.784
Property, Plant and Equipment, Net	$43.276	$1,432.752	$898.93	$32.939
Prepaid Expense, Current	$425.259	$201.962	$504.89	$415.164
Operating Lease, Right-of-Use Asset	$237.983	$449.864	$266.646	$33.66
Other Assets, Current	$888.929	$2,209.544	$852.036	$479.582
Other Assets, Noncurrent	$8.309	$53.91	$53.91	$8.309
Assets, Current	$11,650.843	$70,827.247	$27,094.147	$10,958.887
Assets	$11,940.411	$72,763.773	$28,313.633	$11,033.795
Liabilities	$14,072.229	$4,612.049	$8,289.458	$11,531.102
Accounts Payable, Current	—	—	$2,033.431	$4,278.419
Employee-related Liabilities, Current	$888.381	$1,114.255	$1,269.474	$690.566
Other Liabilities, Current	—	—	$2,643.84	$966.121
Loss Contingency, Accrual, Current	$6,053.468	$1,818.751	$2,069.067	$5,417.25
Operating Lease, Liability, Current	$72.038	$182.428	$189.647	$35.696
Liabilities, Current	$13,900.999	$4,338.887	$8,205.459	$11,531.102
Operating Lease, Liability, Noncurrent	$171.23	$273.162	$83.999	$0
Preferred Stock, Value, Issued	$0	$0	$0	$0
Common Stock, Value, Issued	$12.349	$30.975	$33.379	$35.144
Additional Paid in Capital, Common Stock	$102,238.382	$199,070.421	$206,865.282	$209,637.99
Retained Earnings (Accumulated Deficit)	$-104,382.549	$-130,949.672	$-186,874.486	$-210,170.441
Stockholders' Equity Attributable to Parent	$-2,131.818	$68,151.724	$20,024.175	$-497.307
Preferred Stock, Shares Authorized	200,000	200,000	200,000	200,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	100,000,000	100,000,000	100,000,000	300,000,000
Common Stock, Shares, Issued	12,349,243	30,974,559	33,378,139	35,143,722

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$9,087.548	$58,079.086	$-62,533.243	$-15,769.887
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$10,336.655	$68,415.741	$5,882.498	$-32,389.786
Net Income (Loss) Attributable to Parent	$-37,644.784	$-26,567.123	$-55,924.814	$-50,492.578
Net Cash Provided by (Used in) Operating Activities	$-13,952.178	$-25,237.48	$-43,062.529	$-38,810.453
Proceeds from Divestiture of Businesses, Net of Cash Divested	$5,532.266	$1,358.412	$360.75	$449.587
Payments to Acquire Short-term Investments	—	—	$19,854.723	$19,854.723
Payments to Acquire Property, Plant, and Equipment	$12.55	$1,604.027	$6.312	$0
Net Cash Provided by (Used in) Investing Activities	$6,596.456	$-245.615	$-19,500.285	$23,201.692
Proceeds from Stock Plans	—	—	$29.571	$29.571
Proceeds from Stock Options Exercised	—	$5.618	$0	$0
Net Cash Provided by (Used in) Financing Activities	$16,443.27	$83,562.181	$29.571	$-161.126
Interest Paid, Excluding Capitalized Interest, Operating Activities	$198.352	$433.336	$0	$5.498
Income Taxes Paid	$3.6	$5.2	$5.4	$3.4
Depreciation, Depletion and Amortization	—	$298.64	$723.352	$689.391
Gain (Loss) on Disposition of Other Assets	$4.08	$-10.794	$0	$-597.275
Share-based Payment Arrangement, Noncash Expense	$987.51	$8,317.48	$7,767.694	$6,300.875
Amortization of Debt Issuance Costs and Discounts	$329.89	$599.006	$0	$0
Loss Contingency Accrual, Provision	$-151.843	$-4,234.717	$0	$0
Gain (Loss) on Disposition of Business	$-307.086	$1,358.412	$360.75	$449.587
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	$241.134	$306.764	$0	$0
Debt Conversion, Converted Instrument, Amount	—	—	$0	$0
Increase (Decrease) in Prepaid Expense	$-564.232	$7.703	$302.928	$-1,170.511
Increase (Decrease) in Other Current Assets	$257.79	$1,415.225	$-1,357.508	$-253.841
Increase (Decrease) in Other Noncurrent Assets	—	$45.601	$0	$-45.601
Increase (Decrease) in Accounts Payable, Trade	$-576.384	$-586.533	$1,395.428	$1,055.909
Increase (Decrease) in Employee Related Liabilities	$230.647	$225.874	$155.219	$-177.458
Increase (Decrease) in Other Current Liabilities	$-493.471	$-344.351	$2,308.706	$-892.757
IncreaseDecreaseInOperatingLeaseLiability	$-76.566	$-94.442	$-181.944	$-331.844
Payments of Stock Issuance Costs	—	—	$6,434.447	$6,434.447

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("SKYE","financials")

Full statements spill as a table. For one cell: =jivedata("SKYE","Revenue") or =jivedata("SKYE","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.